Johnson & Johnson-owned franchise, DePuy Synthes Ireland is investing €36 million to establish a 3D Printing Development and Launch Center in order to accelerate its additive manufacturing projects. The company is a global leader in orthopaedic and neurological solutions including hip and knee replacement joints. This new investment focusing strictly on 3D technologies should assert their key role in offering solutions for the medical field, particularly for the orthopaedic field.
DePuy Synthes was acquired in 1998 by Johnson & Johnson and already employs 1,000 people at its Cork facility in Ireland. They are in the process of hiring 30 more people. Indeed, the company in the past had partnered with Aspect Biosystems in order to bioprint human tissues and transform health care thanks to 3D technologies. Therefore, it is a real success for them to have received €36 million from the government in order to make new investments.
As part of the new five year R&D project, the investment expands the scale and scope of activities taking place at the DePuy Synthes Innovation Centre, which has been delivering results for the last 10 years. Furthermore, this new investment also aims to focus on developing the company’s Materials and Surface Technology Centre.
By Carlota V. | 3Dnatives
Image Credit: DePuy Synthes